Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells
Authors
Keywords
IL-15, immunotherapy, TGF-β antagonist, chemotherapy, therapy-induced senescence, NK cells, CD8, T cells, therapeutic antibody, checkpoint blockade, cancer
Journal
MOLECULAR THERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-01-18
DOI
10.1016/j.ymthe.2022.01.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
- (2021) Jiajie Hou et al. Nature Reviews Clinical Oncology
- TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
- (2021) Karen Slattery et al. Journal for ImmunoTherapy of Cancer
- Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors
- (2021) Bai Liu et al. MOLECULAR THERAPY
- Optimising NK cell metabolism to increase the efficacy of cancer immunotherapy
- (2021) Chloe Choi et al. Stem Cell Research & Therapy
- A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy
- (2021) Michelle K. Becker-Hapak et al. Cancer Immunology Research
- Accelerated aging in breast cancer survivors and its association with mortality and cancer recurrence
- (2020) Jingjing Zhu et al. BREAST CANCER RESEARCH AND TREATMENT
- PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15
- (2020) Kyung Hwan Kim et al. Cellular & Molecular Immunology
- Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy
- (2020) David Murray et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of immune cells in the removal of deleterious senescent cells
- (2020) Abhijit Kale et al. Immunity & Ageing
- Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies
- (2020) Lynda Wyld et al. Cancers
- Lingering effects of chemotherapy on mature T cells impair proliferation
- (2020) Rajat K. Das et al. Blood Advances
- Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
- (2019) Jamie N. Justice et al. EBioMedicine
- Senolytics and senostatics as adjuvant tumour therapy
- (2019) Susan Short et al. EBioMedicine
- In vitro Cell Migration, Invasion, and Adhesion Assays: From Cell Imaging to Data Analysis
- (2019) Jordi Pijuan et al. Frontiers in Cell and Developmental Biology
- Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
- (2019) Crystal A. Tonnessen-Murray et al. JOURNAL OF CELL BIOLOGY
- Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
- (2019) LaTonya J. Hickson et al. EBioMedicine
- TGF-β Signaling in Cellular Senescence and Aging-Related Pathology
- (2019) Kana Tominaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Paracrine roles of cellular senescence in promoting tumourigenesis
- (2018) Jose Mario Gonzalez-Meljem et al. BRITISH JOURNAL OF CANCER
- Mechanisms and functions of cellular senescence
- (2018) Nicolás Herranz et al. JOURNAL OF CLINICAL INVESTIGATION
- TPL2 kinase action and control of inflammation
- (2018) Daqi Xu et al. PHARMACOLOGICAL RESEARCH
- Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”)
- (2018) Jeriel T.R. Keeney et al. Oncotarget
- The Senescence–Stemness Alliance – A Cancer-Hijacked Regeneration Principle
- (2018) Maja Milanovic et al. TRENDS IN CELL BIOLOGY
- NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
- (2018) Marcus Ruscetti et al. SCIENCE
- The potential and promise of IL-15 in immuno-oncogenic therapies
- (2017) Tanya O. Robinson et al. IMMUNOLOGY LETTERS
- The Clinical Potential of Senolytic Drugs
- (2017) James L. Kirkland et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
- (2017) Nickhill Bhakta et al. LANCET
- Senescence-associated reprogramming promotes cancer stemness
- (2017) Maja Milanovic et al. NATURE
- Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium
- (2017) Paul J Brighton et al. eLife
- Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
- (2016) Tobias Eggert et al. CANCER CELL
- Morphological and Functional Characteristic of Senescent Cancer Cells
- (2016) Ewa Sikora et al. CURRENT DRUG TARGETS
- Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
- (2016) Megan K. Ruhland et al. Nature Communications
- Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
- (2016) Marco Demaria et al. Cancer Discovery
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Metabolic Regulation of Immune Responses
- (2014) Kirthana Ganeshan et al. Annual Review of Immunology
- Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
- (2013) Ursula J. E. Seidel et al. Frontiers in Immunology
- Senescence: a new weapon for cancer therapy
- (2012) Juan Carlos Acosta et al. TRENDS IN CELL BIOLOGY
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started